My Hair Removal Guide:

Home / Hair Removal Technique / Threading Hair Removal Technique

    Business Editors/Health/Medical Writers

WAYLAND, Mass.--(BUSINESS WIRE)--March 17, 2003

Candela Corporation (NASDAQ: CLZR) announced today that a new family of devices to be launched at next week's American Academy of Dermatology (AAD) Annual Meeting has received 510(k) clearance from the U.S. Food and Drug Administration for the treatment of wrinkles and large leg veins, and for unwanted hair removal. The Company also noted that the new family of devices, named the "MGL" family is 50% faster, 50% smaller, and significantly less expensive than competitive devices.

Gerard E. Puorro, Candela's President and CEO said: "The MGL family is what our market told us they wanted: multi-application devices that have faster treatment times, smaller footprints, and are more economical."

About Candela: Candela Corporation develops, manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 60 countries from offices in the United States, Europe, Japan and other Asian locations. Candela established the aesthetic laser market 14 years ago, and currently has an installed base of over 6,000 lasers worldwide. Candela is an Equal Opportunity and Affirmative Action Employer, M/F/H/V. Visit Candela on the Web at http://www.candelalaser.com.